Chfr is a checkpoint protein that plays an important function in cell cycle progression and tumor suppression, although its exact role and regulation are unclear. Previous studies have utilized overexpression of Chfr to determine the signaling pathway of this protein in vivo. In this study, we demonstrate, by using three different antibodies against Chfr, that the endogenous and highly overexpressed ectopic Chfr protein is localized and regulated differently in cells. Endogenous and lowly expressed ectopic Chfr are cytoplasmic and localize to the spindle during mitosis. Higher expression of ectopic Chfr correlates with a shift in the localization of this protein to the nucleus/PML bodies, and with a block of cell proliferation. In addition, endogenous and lowly expressed ectopic Chfr is stable throughout the cell cycle, whereas when highly expressed, ectopic Chfr is actively degraded during S-G2/ M phases in an autoubiquitination and proteasome-dependent manner. A two-hybrid screen identified TCTP as a possible Chfr-interacting partner. Biochemical analysis with the endogenous proteins confirmed this interaction and identified b-tubulin as an additional partner for Chfr, supporting the mitotic spindle localization of Chfr. The Chfr-TCTP interaction was stable throughout the cell cycle, but it could be diminished by the complete depolymerization of the microtubules, providing a possible mechanism where Chfr could be the sensor that detects microtubule disruption and then activates the prophase checkpoint.
Introduction
The prophase or antephase checkpoint is a p38-dependent, early mitotic checkpoint that responds to a wide variety of cellular stresses. Upon checkpoint activation, early prophase cells transiently return to a late G2 state (Matsusaka and Pines, 2004; Mikhailov et al., 2004) . The ubiquitin ligase Chfr (Checkpoint protein with FHA and RING finger domain) was identified as a crucial component of this checkpoint in specific response to microtubule depolymerization with nocodazole (Scolnick and Halazonetis, 2000) . Yet the exact role of Chfr is still unclear; however, the E3 ubiquitin ligase activity of its RING finger domain appears to be required for a functional checkpoint (Chaturvedi et al., 2002; Kang et al., 2002; Bothos et al., 2003) . It has been proposed that Chfr mediates the prophase arrest through the degradation of the Plk1 kinase; however, no degradation of Plk1 has been observed in cells under checkpoint conditions (Matsusaka and Pines, 2004) , although Chfr preferentially forms Lys-63 polyubiquitin chains , suggesting that Chfr may mediate the checkpoint via ubiquitin signaling, rather than degradation of substrates.
The Chfr gene is expressed ubiquitously in normal tissues, but in human cancer cell lines and in tumors its promoter is frequently hypermethylated, leading to a loss of expression (Erson and Petty, 2003; Satoh et al., 2003) . Mutations in the Chfr gene have been identified in a variety of human cancers, including lung, nasopharyngeal, gastric and breast tumors, leading to the suggestion that Chfr is a tumor suppressor gene candidate (Mizuno et al., 2002; Cheung et al., 2003; Corn et al., 2003; Erson and Petty, 2003; Mariatos et al., 2003) . In support of this, the knockdown of Chfr in immortalized mammary epithelial cells results in a malignant phenotype with cells displaying increased growth rates, invasiveness and colony formation, whereas knockout mice are cancer-prone (Mariatos et al., 2003; Yu et al., 2005; Privette et al., 2007) .
Despite its potential importance in human cancer, very little is known about the regulation of Chfr. Overexpressed Chfr localizes at the promyelocytic leukemia (PML) bodies and a loss of this localization correlates with a loss of Chfr functionality; thus, it has been proposed that the PML-Chfr interaction could regulate Chfr activity (Daniels et al., 2004) . In addition, there is a ubiquitin-dependent degradation of Chfr during M and G1 phases of the cell cycle (Chaturvedi et al., 2002) . However, these studies utilized overexpression of Chfr, and currently there are no data on the regulation of the endogenous form.
Results
Endogenous Chfr is ubiquitinated and phosphorylated in an MPF-dependent manner in Xenopus egg extracts and oocytes To study the regulatory mechanisms involved in the control of the mitotic stress checkpoint, the Xenopus homolog of Chfr was cloned and three different antibodies produced, one directed against the total protein (anti-Chfr) and the other two directed against peptides to the first 12 N-terminal (anti-Nter) and the last 12 C-terminal (anti-Cter) amino acids. All three antibodies recognize a band in interphase (INT) and metaphase II-arrested Xenopus egg extracts (CSF) that co-migrates with in vitro translated Chfr (Rt), although only the antibodies directed against the total protein and the N-terminal peptide were capable of detecting the low levels of Chfr present in XL2 cells (Figure 1a) . Moreover, all three antibodies completely immunodepleted Chfr from CSF, interphase Xenopus egg extracts and XL2 cell lysates ( Figure 1a and data not shown), and therefore the antibodies specifically recognize Chfr.
Chfr immunodepletions performed in CSF extracts produced a smeared signal above the focused endogenous Chfr band in the immunoprecipitate. It is possible that this smeared form of Chfr could correspond to the ubiquitination of this protein in the mitotic extracts. Therefore, an immunoprecipitation using antibodies directed against the full-length protein was performed with 20 ml of CSF extracts, and the smeared bands were excised and sequenced by MALDI-MS-MS mass spectrometry (Figure 1b) . The results showed that the focused band corresponded exclusively to Chfr, whereas Chfr and ubiquitin were present in all of the sequenced smeared bands, indicating that endogenous Chfr is continuously ubiquitinated in CSF extracts.
The overexpressed form of Chfr can target itself for degradation in mitotic cells through autoubiquitination (Chaturvedi et al., 2002) ; however, no change was observed in the levels of endogenous Chfr in CSF extract, and the addition of the protein synthesis inhibitor cycloheximide or the proteasome inhibitor MG132 had no effect on Chfr levels (Figure 1c) . Thus, the ubiquitination of endogenous Chfr in these extracts is not involved in its proteolysis. Similar results were obtained in U2OS cells stably transfected with Chfr, where no Chfr degradation was detected throughout the cell cycle. Furthermore, this stable pool of Chfr was phosphorylated during mitosis . It is possible that this mitotic phosphorylation of Chfr is dependent on cyclin B-cdc2. To test this hypothesis, we used G2-arrested Xenopus oocytes in which maturation is induced by the addition of progesterone. In these oocytes, progesterone promotes an initial activation of cyclin B-cdc2 and thus maturation or germinal vesicle breakdown (GVBD). Maturation is followed by a partial proteolysis of cyclin B and a consequent decrease of cyclin B-cdc2 activity. Re-synthesis of cyclin B then ensues, the mitotic kinase is reactivated and the oocytes arrested at metaphase II. The addition of cycloheximide after GVBD prevents cyclin B re-synthesis and the subsequent re-activation of cyclin B-cdc2, thus providing a model for assessing the dependence of Chfr phosphorylation on cyclin B-cdc2 activity. G2-arrested oocytes were divided into two groups; the first was supplemented with progesterone and the second was supplemented with progesterone, and 30 min after GVBD, with cycloheximide. Three oocytes per time point were removed and Chfr was analysed by western blot. A clear retardation in the electrophoretic mobility of Chfr induced by the phosphorylation of this protein (Supplementary Figure S1 ) was observed just after GVBD when cyclin B-cdc2 was activated (noted by the phosphorylation shift seen for cyclin B at GVBD), and it remained in this form throughout the experiment (Figure 1d ). However, when cyclin B-cdc2 reactivation was prevented by the addition of cycloheximide, the electrophoretic mobility of Chfr returned to its original non-phosphorylated state. In addition, Chfr levels did not decrease after cycloheximide treatment, confirming that Chfr is stable in maturing oocytes and is phosphorylated directly or indirectly by cyclin B-cdc2.
Endogenous Chfr is stable throughout the cell cycle and present in the mitotic spindle The stability and localization of endogenous Chfr was then analysed in XL2 and XTC cells, respectively. Xenopus XL2 cells were synchronized at the G1/S boundary by aphidicolin block and then released into the cell cycle. Samples were taken at various intervals for western blot and flow cytometry analysis (FACS) . Approximately 70% of cells synchronously entered the cell cycle, with peak mitosis at 12 h after release (Figure 2a) . Samples corresponding to G1, S, G2 and M phases showed no change in the levels of the Chfr protein. Immunofluorescent staining of Xenopus XTC cells mirrored the western blot data, with no obvious change in the total levels of Chfr throughout the cell cycle and with a majority of the staining localized to the cytoplasm (Figure 2b ). Subcellular fractionation of XL2 cells confirmed this localization with a significant proportion of endogenous Chfr present in the soluble cytosolic fraction, whereas no protein was detected in the extracted nuclear fraction (Figure 2c ). More importantly, there was a partial but clear localization of endogenous Chfr in the mitotic spindle (Figure 2b ). This localization was first detected at prophase, increased during metaphase and early anaphase, decreased at late anaphase and disappeared completely at telophase. Similar staining was observed with the anti-Cter Chfr antibody (data not shown).
Exogenous Chfr is nuclear and degraded in an autoubiquitination-dependent manner The data presented here on the endogenous form of Chfr are in contradiction with the previously published In accordance with previous reports (Daniels et al., 2004) , overexpressed Chfr displayed a clear nuclear staining, characterized by the accumulation in large and small focal structures that likely correspond to the PML bodies ( Figure 3a) . Thus, ectopic and endogenous Chfr proteins localize in opposite cellular compartments. Furthermore, no mitotic YFP-Chfr-transfected cells were observed (data not shown); thus, the cell cycle distribution of the YFP-Chfr-expressing population was analysed. The transfected XL2 cells were synchronized and analysed by two-dimensional flow cytometry. In agreement with the fluorescence microscopy results, no YFP-Chfr-expressing cells contained a 4n DNA, indicating either that YFP-Chfr is degraded during the S/G2 phases of the cell cycle or that YFP-Chfr overexpression blocks cell cycle progression in the G1 phase (Figure 3b ).
The degradation of the ectopic-expressed Chfr protein is dependent on its RING finger domain and associated autoubiquitination activity (Chaturvedi et al., 2002) . Therefore, to assess if ectopic Chfr blocks cell cycle progression or is degraded, synchronized HeLa cells were transfected with either the YFP-wild-WT or the YFP-RING Finger (DRFD) mutant of Chfr, and the cell cycle distribution of the overexpressed cells was analysed. Cells transfected with the DRFD mutant contained a twofold number of YFP-positive cells and a fourfold level of expression of this protein per cell in comparison with WT-transfected cells (data not shown). Western blots confirmed this observation with approximately six times less WT Chfr, compared with the DRFD mutant in G1/S cell lysates (Figure 3c ). In (a) Western blot analysis (WB) of Chfr-programmed reticulocyte lysate (2 ml), interphase (INT) and CSF Xenopus egg extracts (2 ml), as well as of total XL2 cell lysate (40 mg), was performed with antibodies directed against the full-length Chfr protein (anti-Chfr), the first 12 N-terminal amino acids (anti-Nter) and the last 12 C-terminal amino acids (anti-Cter). CSF and interphase Xenopus egg extracts (20 ml), as well as XL2 cell lysate (300 mg of total protein) were immunoprecipitated with anti-Chfr (IP-Chfr), anti-Cter (IP-Cter) or with anti-Nter (IP-Nter) antibodies. A 2 ml volume of CSF and interphase extracts and of the supernatant, as well as the whole amount of the immunoprecipitate was analysed by western blot. Thirty micrograms of total XL2 cell lysate and supernatant, as well as an equivalent of 100 mg of the immunoprecipitate, was analysed by western blot with anti-Chfr antibodies. (b) A 20 ml volume of CSF extracts was immunoprecipitated with anti-Chfr antibodies. The immunoprecipitate was divided into three parts. One-third was used for western blot analysis with anti-Chfr antibodies and the rest was stained with Coomassie Blue. The indicated bands were excised and treated to be sequenced by MALDI-MS-MS. (c) CSF extracts were incubated with either cycloheximide (CSF þ CHX) or MG132 (CSF þ MG132) to a final concentration of 100 mg/ml and 1 mM, respectively, and 2 ml of the mix was removed at the indicated time points and used to analyse Chfr levels by western blot. (d) G2-arrested oocytes were treated with progesterone and supplemented ( þ CHX) or not (ÀCHX) with cycloheximide 30 min after GVBD. Three oocytes per point were taken and lysed. The volume corresponding to one oocyte was then used to examine Chfr and cyclin B by western blotting. Asterisk (*) denotes a nonspecific band recognized by the anti-cyclin B antibody.
addition, there was a clear decrease in the total levels of WT protein during the S phase and, to a lesser extent, the G2/M phase, which could be reversed by the S-phase addition of the proteasome inhibitor MG132. Furthermore, the addition of MG132 to asynchronous cells transfected with WT protein for 24 h restored the level of expression of the WT protein to similar levels of the DRFD mutant (Figure 3d ).
FACS analysis of the overexpressed populations mirrored the western blot data. Transfection of WT construct induced a clear accumulation of approximately 80% of YFP-positive cells in G1 phase. The addition of nocodazole failed to alter this pattern; however, the S-phase addition of MG132 resulted in the accumulation of WT-Chfr cells in the G2/M phase with a 4n DNA content. In contrast, DRFD-transfected cells presented a pattern similar to non-transfected cells even after treatment with nocodazole and MG132, although a slight accumulation in G1 was also observed (Figure 3e ). These results demonstrate that the WT protein is degraded throughout the cell cycle by the proteasome in an autoubiquitination-dependent manner. Therefore, it is possible that the accumulation at G1 observed in WTtransfected cells is the result of degradation of YFP-WT Chfr during S and G2/M phases; however; the possibility cannot be excluded that in addition to degradation, the overexpression of the WT-Chfr may also block cell cycle progression in the G1 phase. Cells were taken at the indicated times after release and analysed by FACS and western blot to determine cell synchronization and to examine the levels of Chfr. (b) XTC cells were fixed with 3.7% formaldehyde, permeabilized with 0.25% Triton X-100 and blocked with PBS-5% fetal bovine serum. Subsequently, coverslips were incubated with anti-Chfr antibody (affinity purified, 4 mg/ml) and anti-b-tubulin (mAB, 1:10). Anti-mouse Alexa 488 and anti-rabbit Alexa 555-conjugated two antibodies (1/600 and 1/1000, respectively, Molecular Probes, Leiden, The Netherlands) and DAPI (10 mg/ml) were used. Scale bar ¼ 5 mm.
(c) Asynchronous XL2 cells (300 mg) were lysed as described in Materials and methods, and the cytosolic soluble fraction (Cy) and the nuclear fraction (Nu) were immunoprecipitated with anti-Chfr antibodies. The immunoprecipitates were then subjected to western blot to analyse Chfr and b-tubulin levels in each fraction. Figure S2) . Furthermore, no mitotic cells were observed in this group, with a twofold increase in expression of ectopic Chfr in the interphase population compared with mitotic cells, indicating that high overexpression of Chfr might block cell cycle progression (Figure 4c, Int) . Second, and more commonly (76%), a weak diffuse total cytoplasmic staining was observed. Of the 50 analysed cells, 6 cells underwent mitosis, and all contained a weak diffuse staining, with no nuclear foci observed throughout the time course (Figure 4b ). The low expression of Chfr in mitotic cells remained stable (Figure 4c , mitotic) and a distinct localization at the mitotic spindle, similar to the one obtained for the endogenous protein, was observed ( Figure 4b , and Supplementary Figure S3 ). These results indicate that when expressed at low levels, exogenous Chfr is not degraded and does not affect cell cycle progression. MG132 treatment of interphase cells presenting a weak diffuse staining shifted the balance toward a nuclear foci localization ( Figure 4d ) and prevented the decline in expression of interphase cells over time (Figure 4c, MG132) . Thus, preventing the proteasome degradation of Chfr promotes the nuclear and PML-like foci localization of the protein.
More detailed analysis of the earlier FACS data confirmed the live cell imaging results. Synchronized HeLa cells were harvested as they underwent mitosis were and processed by FACS. For analysis, cells were sub-divided into high, medium, low and non-Chfr overexpressing fractions. The percentage of cells in G1, S and G2/M phases was then quantified. Both the high and medium overexpressing Chfr cells remained primarily in G1 phase, whereas only the low-expressing cells were present in the G2/M phase (Figure 4e ).
In summary, it is clear that there is a threshold for Chfr within cells. Below this threshold, Chfr is stable, does not perturb cell cycle progression and is localized to the cytoplasm and the mitotic spindle. Above this threshold, Chfr is nuclear, often localizing to PML-like foci, and actively degraded and blocks cell cycle progression at G1.
Chfr binds b-tubulin and the translationally controlled tumor protein in Xenopus egg extracts and in XL2 cells Since Chfr detects mitotic stress during prophase, we hypothesized that its spindle localization might be important for its function. To further characterize the Chfr signaling pathway and spindle localization, a yeast two-hybrid screen was performed to identify novel Chfr-interacting proteins. Full-length amino acids of Chfr were used as baits to screen a cDNA library obtained from a 6 to 8-week-old human embryo. One of the positive clones isolated was the translationally controlled tumor protein (TCTP). Mating assays subsequently confirmed an interaction between LexA-Chfr and TCTP. Rabbit polyclonal antibodies were produced against bacterially expressed full-length Xenopus TCTPglutathione S-transferase (GST) to further investigate the endogenous interaction between Chfr and TCTP. The affinity-purified antibodies recognized a single band that migrated at the expected molecular weight of approximately 25 kDa in CSF, interphase Xenopus egg extracts and XL2 cells (Figure 5a ). Unfortunately, despite multiple rounds of immunoprecipitation, only a very low quantity of TCTP was present in the immunoprecipitation, with the bulk of the protein remaining in the supernatant (Figure 5a and data not shown).
Gel filtration performed on interphase extracts showed that a small amount of endogenous TCTP coeluted with Chfr. The peak fraction of Chfr eluted in fractions corresponding to 140-240 kDa, whereas the majority of TCTP eluted in fractions corresponding to 43 kDa. However, a small but repetitive fraction of TCTP co-eluted with the peak of Chfr (Figure 5b) .
The endogenous interaction was further analysed by immunoprecipitation with anti-Chfr or anti-TCTP antibodies in CSF and XL2 extracts. Owing to the low immunoprecipitation capacity of the anti-TCTP antibodies (Figure 5a ), no Chfr was detected in the anti-TCTP immunoprecipitate (data not shown) and, therefore the reverse experiment was performed. A weak but consistent band corresponding to TCTP was obtained in the Chfr immunoprecipitate from CSF and XL2 extracts (Figure 5c ). This band was specific as similar results were obtained with the full-length, antiCter or anti-Nter Chfr antibodies. Moreover, the interaction could no longer be detected after the complete depletion of Chfr by several rounds of immunoprecipitation from the extracts (Figure 5c ).
Given the mitotic spindle localization of Chfr, the ability to interact with tubulin was also assessed. Similar to TCTP, a small reproducible quantity of b-tubulin was present in Chfr immunoprecipitations, which disappeared after depletion of Chfr from the extract (Figure 5c ), indicating that this interaction is specific. (Gachet et al., 1999) ; however, we failed to observe this localization, with TCTP primarily localized to an undefined cytoplasmic structure (Figure 5d ). During mitosis, a clear staining of the mitotic spindle was observed. This staining started at prophase, increased during metaphase and anaphase, and completely disappeared at telophase. Thus, both Chfr and TCTP are present at the mitotic spindle with similar kinetics.
The Chfr-TCTP interaction is independent of the cell cycle but is dependent on microtubules The mitotic stress checkpoint responds to a depolymerization of microtubules by mitotic poisons. TCTP and tubulin both co-immunoprecipitate with Chfr and are located at the mitotic spindle. It is possible that this association could be involved in the activation of this checkpoint. To investigate this hypothesis, we first determined the interaction between Chfr and TCTP throughout a normal cell cycle. XL2 cells were synchronized by aphidicolin block, and immunoprecipitation with anti-Chfr antibodies was performed on samples corresponding to the various phases of the cell cycle. A clear association that remained constant throughout the cell cycle was observed between Chfr and TCTP indicating that this association is not cell cycle regulated (Figure 6a ). To analyse the interaction during the prophase checkpoint, nocodazole (1 mM) was added during the S phase to synchronized XL2 cells. No difference in the association was observed between TCTP and Chfr in the presence or absence of nocodazole despite the activation of the Chfr checkpoint, noted by the delay in the mitotic index in nocodazole-treated cells (Figure 6b ). The strength and stability of the Chfr-b-tubulin-TCTP interactions in soluble XL2 extracts were then determined. Binding of TCTP to Chfr was resistant up to 500 mM NaCl washing but was sensitive to detergent (1% IGEPAL-C630), whereas b-tubulin was resistant to both 500 mM NaCl and detergent, suggesting that tubulin binds more tightly to Chfr than TCTP and thus may mediate the interaction.
Therefore, to determine if the Chfr-TCTP interaction is dependent on the presence of stable microtubules, interphase extracts were treated on ice for 30 min in the absence (Con) or in the presence of 10 mM nocodazole (Noc) to completely depolymerize the microtubules (Rieder and Cole, 2000) and then subjected them to Chfr immunoprecipitation. Comparable levels of Chfr were present in both control and nocodazole-treated extracts and precipitates, with a clear association between Chfr and both TCTP and b-tubulin in the control extracts. Treatment with nocodazole (a) Affinity-purified anti-full-length TCTP antibodies (anti-TCTP) were used to probe CSF and interphase Xenopus egg extracts (2 ml) as well as XL2 cells (40 mg total protein). A 20 ml volume of CSF extract was immunoprecipitated with anti-TCTP antibodies. An equal amount of CSF and supernatant (2 ml), as well as the total immunoprecipitate (corresponding to 20 ml of extract), was loaded in the gel and probed with anti-TCTP antibodies. (b) Side-by-side analysis by western blot of consecutive fractions (30 ml loaded) after chromatography of a CSF extract by gel filtration on Superdex 200 column. Upper panel: blot probed with affinity-purified antibodies against Chfr. Lower panel: blot probed with affinity-purified antibodies against TCTP. (c) XL2 cells (300 mg total protein) or CSF extracts (20 ml) were immunoprecipitated with full-length Chfr (Chfr IP), anti-N terminal Chfr (Nter IP) or anti-C terminal Chfr antibodies (Cter IP). An equal amount of supernatants and CSF extracts (2 ml) and XL2 cell lysate (40 mg) and the total amount of the immunoprecipitate were loaded and probed against Chfr and TCTP. To confirm the specificity of the interaction, Chfr immunoprecipitations were performed on 20 ml of interphase extract (Int) and on 20 ml of Chfr-depleted interphase extract (Dep). For western blot analysis of b-tubulin and TCTP, samples were re-suspended in Laemmli buffer without b-Mercapto-ethanol (b-M) and no boiling was performed to prevent the migration of IgG. Under these conditions, TCTP and b-tubulin present an abnormal electrophoretic mobility. For Chfr visualization, samples were boiled in the presence of b-M. (d) XTC cells were treated as described in Figure 2b except that anti-TCTP instead of anti-Chfr primary antibodies were used. Scale bar ¼ 5 mm.
Chfr binds TCTP and tubulin
A Burgess et al significantly decreased the interaction between Chfr, b-tubulin and TCTP (Figure 6d ). Therefore, microtubules might play a significant role in mediating the interaction between Chfr and TCTP.
Discussion
The Chfr gene is ubiquitously expressed in normal tissues, but in human cancer cell lines and tumors its promoter is frequently hypermethylated (Erson and Petty, 2003; Satoh et al., 2003) . Despite its potential importance in cancer, the function of Chfr is poorly understood, possibly due to its low cellular levels and the poor availability of sensitive, robust antibodies.
Consequently, all current data on Chfr have been obtained using the overexpressed protein with no information available for the endogenous protein.
In this study, we produced three different Chfr antibodies that specifically recognize and immunoprecipitate Chfr either in Xenopus egg extracts or in XL2 cells in culture and analyse for the first time the endogenous Chfr protein. Endogenous Chfr can be ubiquitinated under certain conditions, is stable throughout the cell cycle, and is phosphorylated during mitosis in a cyclin B-cdc2-dependent manner. In addition, the immunofluorescence and sub-cellular fractionation of cells show that endogenous Chfr localizes in the cytoplasm during interphase, whereas during mitosis it partially migrates to the mitotic spindle where it is present until late anaphase. This localization of endogenous Chfr protein is in contrast with previous reports that described the ectopic protein as nuclear and localized to PML foci (Chaturvedi et al., 2002; Daniels et al., 2004) . In agreement, we found that high overexpression of the ectopic protein results in a nuclear localization, with a distinct punctuate-like staining that likely correspond to PML bodies. However, this highly overexpressed nuclear Chfr was degraded during the cell cycle in an autoubiquitination-dependent manner and caused a G1 cell cycle arrest. Notably, overexpression of the yeast homolog of Chfr in Saccharomyces cerevisiae can induce both G1 and G2 arrests (Loring et al., 2008) . At lower levels, exogenous Chfr behaved similar to the endogenous protein, with both proteins stable throughout the cell cycle and localizing to the cytoplasm during interphase, and to the spindle during mitosis. Therefore, there appears to be a threshold for Chfr expression within cells, endogenous or exogenous, which is permissive to normal cell cycle progression. Above this level, Chfr is redistributed to the nucleus, is actively degraded by the proteasome in an autoubiquitinationdependent manner and blocks cell cycle progression.
To identify novel Chfr-interacting proteins that could colocalize to the mitotic spindle, a two-hybrid screen was undertaken. Through this screen, TCTP was identified as a novel interacting partner for Chfr. TCTP is a ubiquitous, highly expressed protein that has been implicated in a wide variety of cellular functions, including microtubule stabilization (Gachet et al., 1999; Yarm, 2002) , anti-apoptotic function, Na/KATPase inhibition (Jung et al., 2004) or as a guanine nucleotide exchange factor (Hsu et al., 2007) . Furthermore, TCTP has been implicated in cancer with knockdown of TCTP, enabling tumor reversion (Tuynder et al., 2002 (Tuynder et al., , 2004 , whereas overexpression can protect cells from apoptosis (Liu et al., 2005; Yang et al., 2005) . The specificity of the Chfr-TCTP interaction was confirmed by immunoprecipitation of endogenous Chfr from Xenopus extracts and cell lines, with a small but consistent quantity of TCTP present. Furthermore, this association did not vary throughout the cell cycle, and both proteins were present at the mitotic spindle with similar kinetics. Interestingly, TCTP has previously been shown to bind with and co-elute on gel filtrations with tubulin (Gachet et al., 1999) . Therefore, there seemed a strong possibility that Chfr may also interact with tubulin. Accordingly, immunoprecipitation data confirmed that a small quantity of b-tubulin specifically binds with Chfr. Both the TCTP-Chfr and tubulin-Chfr interactions were resistant to salt, but TCTP was highly sensitive to detergent, suggesting that the interaction between Chfr and tubulin was stronger and possibly mediating the Chfr-TCTP interaction. In support of this, depolymerization of the microtubules by high-dose nocodazole greatly reduced the Chfr-b-tubulin-TCTP interaction.
The Chfr-dependent prophase checkpoint responds specifically to microtubule damage by delaying entry into mitosis. We hypothesize that Chfr is the sensor for microtubule depolymerization. First, it could be localized by its association with TCTP at the mitotic spindle.
The disruption of the spindle could then liberate TCTP and Chfr, allowing Chfr to interact with additional substrates, such as the mitotic kinase's Aurora A and Plk, thereby preventing the onset of mitosis. However, no decrease in the total Chfr-TCTP interaction was detected during the checkpoint response in cells, although it is possible that only the spindle localized form of Chfr is affected by checkpoint activation, and thus our experiments may not be sensitive enough to detect this dissociation. Unfortunately, we failed to successfully knock down TCTP through siRNA in Xenopus cell lines and thus have been unable to determine if TCTP binding to Chfr protects the latter from being degraded. Therefore, more research is needed, preferably in mammalian cell lines with functional Chfr, where the ability to synchronize and manipulate gene expression through siRNA and stable-inducible expression is more feasible. Unfortunately, there are no antibodies currently available that are capable of detecting the endogenous mammalian Chfr protein, limiting the advancement of this research field.
In summary, the above data demonstrate for the first time that endogenous Chfr is stable throughout the cell cycle and partially localizes to the mitotic spindle with the tumor protein TCTP and tubulin. All three proteins are present in a complex that is partially dependent on the presence of microtubules, providing a mechanism where Chfr could be the sensor for microtubule disruption, and when dissociated from the spindle, it is then able to prevent mitotic entry through interaction with its mitotic substrates.
Materials and methods
c-DNA cloning, immunization procedures, protein purification and antibodies Xenopus Chfr and TCTP cDNA were amplified from total mRNA of Xenopus metaphase II-arrested eggs and subcloned into a PCS2 þ vector. For immunization, Xenopus Chfr and TCTP were amplified and subcloned in the pGEX4T1 vector. Immune sera were obtained from fusion proteins and anti-Nter and anti-Cter antibodies were obtained as previously described (Abrieu et al., 2001) .
For cell transfection, Chfr was subcloned in the pYFP-C1 vector. Cell culture and synchrony HeLa cells were grown in Dulbecco's modified Eagle's medium supplemented with 3 mM 4-(2-hydroxyethyl)-1-piperazineethane sulfonic acid (HEPES) and 10% (v/v) fetal calf serum (Invitrogen, Carlsbad, CA, USA). Thymidine block/ release synchronizations were performed as previously described (Gabrielli et al., 1996) . XL2 cells were cultured in L-15 media supplemented with 10% fetal calf serum, L-glutamine and HEPES. Cells were synchronized by blocking for 30 h with 2 mg/ml aphidicolin and releasing into fresh media after three washes (Uzbekov et al., 1998) .
Flow cytometry
Flow cytometry (FACS) was performed as previously described (Burgess et al., 2006) . The stained cells were acquired on a FACS Calibur (Becton Dickinson, Franklin Lakes, NJ, USA) using Cell Quest Pro software. Cell cycle distributions of YFP-positive cells were analysed using Cell Quest Pro software, the YFP FACS fluorescence signal was divided into three different areas corresponding to G1, S and G2/M phases with respect to the DNA content, and the cells in each area were counted and expressed as the percentage of total YFP-positive population.
Live cell imaging
Upon release from G1/S phase, cells were filmed with a Leica DMIRE2 inverted microscope controlled by Metamorph 7.1 software (Molecular Devices, Sunnyvale, CA, USA). Images, differential interference contrast (DIC) and YFP fluorescence were taken every hour for 25 h, with the total fluorescence measured for each cell with Metamorph 7.1 software.
Two-hybrid analysis A cDNA library was constructed with human mRNAs isolated from three complete 6-to 8-week-old human embryos. The cDNA library was then transformed into a MATa Y187 yeast strain. The human Chfr bait plasmid was constructed in frame with a downstream GAL4 DNA-binding domain in plasmid pGBT9 and then transformed into MATa CG1945 yeast cells. Yeast two-hybrid screening was conducted as previously described (Fromont-Racine et al., 1997) . A total of 215 positive clones on the histidine-depleted plates and 45 blue spots in the B-Gal test were obtained. A PCR reaction was carried out using yeast clones and the product was sequenced.
Immunoprecipitation and Xenopus XL2 and egg extracts Immunoprecipitations were carried out using 20 ml of magnetic Protein A-Dynabeads (Invitrogen) and 3 mg of each antibody. Beads were washed and incubated for 30 min at room temperature with 20 ml of Xenopus egg extracts.
For hypotonic lysis, cells were swollen for 10 min on ice in hypotonic lysis buffer (20 mM Tris, 1 mM EDTA, 1 mM EGTA (ethylene glycol bis(b-aminoethylether)-N,N,N 0 ,N 0 ,-tetraacetic acid)), lysed by 30 strokes with a 1 ml syringe and 26-gauge needle, spun at 2500 r.p.m. for 10 min and the supernatant was collected (soluble cytosolic fraction). The nuclear pellet was washed once with hypotonic buffer and extracted with the same buffer containing 400 mM NaCl and 0.25% IGEPAL-C630. CSF and interphase egg extracts were prepared from Xenopus eggs as previously described (Murray and Kirschner, 1991) .
